NovoCure (NVCR) Change in Account Payables (2014 - 2019)

NovoCure (NVCR) has reported Change in Account Payables for 6 consecutive years, with $126000.0 the latest figure, recorded in Q2 2019.

• Quarterly Change in Account Payables fell 87.6% year-over-year to $126000.0 in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $9.6 million (up 32.44% YoY) and the FY2018 annual result came in at $9.5 million, up 926.35% from the prior year.
• Change in Account Payables eased to $126000.0 in Q2 2019 per NVCR's latest filing, from $3.2 million in the prior quarter.
• Over the last five years, Change in Account Payables for NVCR reached as high as $6.7 million in Q4 2018 and fell as low as -$6.8 million in Q3 2016.
• A 5-year average of $1.1 million and a median of $1.7 million in 2015 frame the typical range for Change in Account Payables.
• The largest YoY upside for Change in Account Payables was 371.28% in 2016 against a maximum downside of 547.42% in 2016.
• Year by year, Change in Account Payables stood at $2.4 million in 2015, then jumped by 78.6% to $4.2 million in 2016, then slipped by 27.45% to $3.1 million in 2017, then soared by 117.27% to $6.7 million in 2018, then slumped by 98.11% to $126000.0 in 2019.
• According to Business Quant data, Change in Account Payables over the past three periods registered $126000.0, $3.2 million, and $6.7 million for Q2 2019, Q1 2019, and Q4 2018 respectively.